Fri, Aug 29, 2014, 10:09 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Seattle Genetics Inc. Message Board

peter_parker0_0_7 2 posts  |  Last Activity: Aug 15, 2014 11:18 AM Member since: Jan 3, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • The federal appeals court handling Vringo's suit against Google has ruled against Vringo, arguing the patent claims it asserts "disclose no new technology, but instead simply recite the use of a generic computer to implement a well-known and widely-practiced technique for organizing information."

    The appeals court cites a recent Supreme Court ruling that upheld the patentability of software concepts, but barred companies from patenting a mere abstract idea on a computer.
    Vringo has been halted. Shares plunged shortly before the halt.

    The federal appeals court handling Vringo's (VRNG -10.8%) suit against Google has ruled against Vringo, arguing the patent claims it asserts "disclose no new technology, but instead simply recite the use of a generic computer to implement a well-known and widely-practiced technique for organizing information

    The appeals court cites a recent Supreme Court ruling that upheld the patentability of software concepts, but barred companies from patenting a mere abstract idea on a computer.

    GET OUT AS FAST AS YOU CAN.

    Sentiment: Strong Sell

  • Adcetris could be pulled off the shelves because of Hepatotoxicity. If that happens, 70%-80% drop here could happen as Adcetris is the only FDA approved drug SGEN has. HUGE risk here.

    Sentiment: Strong Sell

SGEN
44.01+0.44(+1.01%)Aug 29 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.